Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIronveld Regulatory News (IRON)

Share Price Information for Ironveld (IRON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0675
Bid: 0.067
Ask: 0.068
Change: 0.00 (0.00%)
Spread: 0.001 (1.493%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.0675
IRON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Posting of GM Circular

27 Nov 2020 16:49

RNS Number : 8246G
Ironveld PLC
27 November 2020
 

Ironveld plc

Posting of GM Circular and Amendment to Directors' Settlement Shares

General Meeting

 

Ironveld plc ("Ironveld" of "the Company"), announces that it has today posted a Shareholder Circular in respect of the General Meeting to be held at 10.00 am at the offices of Kuit Steinart Levy LLP, 7th Floor, Blackfriars House, The Parsonage, Manchester M3 2JA on 14 December 2020.

 

The Shareholder Circular will shortly be available to view at www.ironveld.com.

 

Directors Settlement Shares

 

Following the announcement on 26 November 2020 the Board has engaged with its major shareholders in respect of the proposed capitalisation of accrued Director salary / fees. The Board acknowledges that a substantial proportion of these salary / fees relate to periods when the Company's share price was higher than the proposed Placing Price and has therefore agreed that a settlement based on the volume weighted average price of the Company's shares during the periods in which salary / fees were deferred would be more appropriate.

This will result in the number of Director Settlement Shares being issued in satisfaction of the £780,900 of deferred fees decreasing from 260,299,999 to 52,774,570, at an effective issue price per share of 1.48 pence. Any deferred sums remaining due to Chief Executive Martin Eales and settled in equity at a later date will be similarly calculated.

The revised table of Directors' interests, conditional on approval of all resolutions at the General Meeting, will therefore be:

Director's name

No of Existing Ordinary Shares

% of Existing Share Capital

Salary Shares and Loan Settlement Shares

No of New Ordinary Shares (on Admission)

% of Enlarged Share Capital (on Admission)

Giles Clarke*

21,211,050

3.24%

8,538,231**

29,749,281

2.29

Nick Harrison*

17,210,310

2.63%

5,204,898

22,415,208

1.73

Peter Cox

259,161

0.04%

28,526,239

28,785,400

2.22

Vred von Ketelhodt

262,500

0.04%

13,838,534

14,101,034

1.09

 

*Giles Clarke and Nick Harrison are both beneficially interested in 10,062,470 Ordinary Shares held by Westleigh Investments Limited.

** including 3,333,333 New Ordinary Shares resulting from the conversion of Loan Facilities.

 

Each of them is a related party of the Company for the purposes of the AIM Rules by virtue of their status as Directors of the Company. Martin Eales, being the independent director for this purpose, considers, having consulted with the Company's nominated adviser, finnCap, that the terms of such conversion is fair and reasonable insofar as the Company's shareholders are concerned.

 

The maximum number of Transaction Shares that may therefore be issued decreases from 848,141,628 to 640,616,199.

 

Capitalised terms used in this announcement have the meanings given to them in the announcement of the conditional Placing on 26 November 2020.

 

 

**ENDS**

 

For further information, please contact:

Ironveld plc

Giles Clarke, Chairman

Martin Eales, Chief Executive Officer

 

c/o Blytheweigh

+44 20 7138 3204

 

finnCap (Nomad and Joint Broker)

Christopher Raggett / Charlie Beeson

 

+44 20 7220 0500

Turner Pope (Joint Broker)

Andrew Thacker

 

+44 20 3657 0050

Blytheweigh

Tim Blythe / Megan Ray

+44 20 7138 3204

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQDLFLBFLZFBV
Date   Source Headline
2nd May 20247:00 amRNSAppointment of CEO
24th Apr 20247:00 amRNSWorking Capital Facility
23rd Apr 20247:00 amRNSBlocklisting Return
2nd Apr 20245:30 pmRNSTR-1: Notification of major holdings
28th Mar 20247:00 amRNSInterim results for the 6 months ended 31 Dec 2023
29th Feb 202411:36 amRNSTR-1: Notification of major holdings
23rd Feb 20247:00 amRNSTR-1: Notification of major holdings
23rd Feb 20247:00 amRNSReceipt of Non-Binding Term Sheet and Board Change
7th Feb 20243:20 pmRNSTR-1: Notification of major holdings
2nd Feb 20241:48 pmRNSWorking Capital Facility
10th Jan 202410:45 amRNSResult of Annual General Meeting
22nd Dec 20237:00 amRNSNotice of AGM
20th Dec 20237:00 amRNSFinal Results for the year ended 30 June 2023
14th Nov 20231:40 pmRNSTR-1: Notification of major holdings
13th Nov 20232:10 pmRNSResult of General Meeting and Total Voting Rights
8th Nov 202311:50 amRNSTR-1: Notification of major holdings
7th Nov 20234:45 pmRNSTR-1: Notification of major holdings
27th Oct 20234:07 pmRNSPosting of Circular and Notice of General Meeting
26th Oct 20237:00 amRNSFundraising at a premium and Board change
23rd Oct 20237:00 amRNSBlocklisting Return
18th Sep 20237:00 amRNSOperations Update
1st Sep 20237:00 amRNSUpdate on DMS Magnetite Joint Venture
21st Jul 20232:45 pmRNSTR-1: Notification of major holdings
14th Jul 20231:06 pmRNSDirector’s Dealing
13th Jul 20232:08 pmRNSDirector’s Dealing
12th Jul 20232:50 pmRNSTR-1: Notification of major holdings
4th Jul 20238:05 amRNSTR-1: Notification of major holdings
28th Jun 20237:00 amRNSFirst Sales Achieved
27th Jun 202311:56 amRNSTR-1: Notification of major holdings
6th Jun 202310:54 amRNSIssue of Equity
5th Jun 20237:00 amRNSBoard Appointment
17th May 20232:13 pmRNSWebinar Presentation
12th May 20237:00 amRNSOperations Update
24th Apr 20237:00 amRNSBlocklisting Return
4th Apr 202312:20 pmRNSDirector Dealings
3rd Apr 20237:00 amRNSLOI signed with BurnStar Technologies
30th Mar 20237:00 amRNSInterim results for the 6 months ended 31 Dec 2022
29th Mar 202310:00 amRNSAcquisition Unconditional
15th Mar 20234:32 pmRNSTR-1: Notification of major holdings
15th Mar 202311:13 amRNSTR-1: Notification of major holdings
15th Mar 202310:58 amRNSTotal Voting Rights
13th Mar 202311:15 amRNSResult of General Meeting
2nd Mar 202311:56 amRNSTR-1: Notification of major holdings
2nd Mar 202310:15 amRNSTR-1: Notification of major holdings
1st Mar 20235:36 pmRNSDirector Dealing
1st Mar 20234:56 pmRNSTR-1: Notification of major holdings
28th Feb 20234:15 pmRNSGrant of Share Options
24th Feb 20234:00 pmRNSPosting of GM Circular
24th Feb 20231:25 pmRNSTR-1: Notification of major holdings
23rd Feb 202311:00 amRNSPlacing to raise £2.0 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.